User profiles for M. A. ROGAWSKI

Michael A. Rogawski

Professor of Neurology and Pharmacology, University of California,Davis
Verified email at ucdavis.edu
Cited by 30948

The neurobiology of antiepileptic drugs

MA Rogawski, W Löscher - Nature reviews neuroscience, 2004 - nature.com
RogawskiRogawski, MA & Löscher, W. The neurobiology of antiepileptic drugs for the
treatment … Rogawski, MA in Neurotherapeutics: Emerging Strategies (eds Pullan, L. & Patel, J.) …

Glia and epilepsy: excitability and inflammation

…, S Najjar, NC De Lanerolle, MA Rogawski - Trends in …, 2013 - cell.com
Epilepsy is characterized by recurrent spontaneous seizures due to hyperexcitability and
hypersynchrony of brain neurons. Current theories of pathophysiology stress neuronal …

Neuroprotective and disease-modifying effects of the ketogenic diet

M Gasior, MA Rogawski… - Behavioural pharmacology, 2006 - journals.lww.com
The ketogenic diet has been in clinical use for over 80 years, primarily for the symptomatic
treatment of epilepsy. A recent clinical study has raised the possibility that exposure to the …

d-Serine is an endogenous ligand for the glycine site of the N-methyl-d-aspartate receptor

…, DJ Linden, CD Ferris, MA Rogawski… - Proceedings of the …, 2000 - National Acad Sciences
Functional activity of N-methyl-d-aspartate (NMDA) receptors requires both glutamate
binding and the binding of an endogenous coagonist that has been presumed to be glycine, …

Molecular targets for antiepileptic drug development

BS Meldrum, MA Rogawski - Neurotherapeutics, 2007 - Elsevier
This review considers how recent advances in the physiology of ion channels and other
potential molecular targets, in conjunction with new information on the genetics of idiopathic …

The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions

MA Rogawski, W Löscher - Nature medicine, 2004 - nature.com
Antiepileptic drugs (AEDs) are commonly prescribed for nonepileptic conditions, including
migraine headache, chronic neuropathic pain, mood disorders, schizophrenia and various …

Colchicine myopathy and neuropathy

…, D Watson, K Alderson, MA Rogawski… - … England Journal of …, 1987 - Mass Medical Soc
Although colchicine has been used for centuries, its neuromuscular toxicity in humans is
largely unrecognized. In this report we describe a characteristic syndrome of myopathy and …

The neuropharmacological basis for the use of memantine in the treatment of Alzheimer's disease

MA Rogawski, GL Wenk - CNS drug reviews, 2003 - Wiley Online Library
Rogawski MA. Low affinity channel blocking (uncompetitive) NMDA receptor antagonists
as therapeutic agents — toward an understanding of their favorable tolerability. Amino Acids …

Adjunctive perampanel for refractory partial-onset seizures: randomized phase III study 304

…, H Yang, A Laurenza, D Kumar, MA Rogawski… - Neurology, 2012 - AAN Enterprises
MA Rogawski: drafting or revising the manuscript for intellectual content. … MA Rogawski
has served as a consultant and has received research support from Eisai Inc. Go to Neurology.…

Diverse mechanisms of antiepileptic drugs in the development pipeline

MA Rogawski - Epilepsy research, 2006 - Elsevier
There is a remarkable array of new chemical entities in the current antiepileptic drug (AED)
development pipeline. In some cases, the compounds were synthesized in an attempt …